Letters to the Editor

Comment to “Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO ‘MDS-U’ designation” Haematologica. 2012;97(12):1845-9.

Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel
Service de Génétique Médicale, University of Lausanne, Switzerland
Division of Hematology, University Hospital Basel
Division of Hematology, University Hospital Basel;Blood Transfusion Centre, Swiss Red Cross, Basel
Division of Hematology, University Hospital Basel
Division of Hematology, University Hospital Basel
Vol. 98 No. 4 (2013): April, 2013 https://doi.org/10.3324/haematol.2012.082875